Fulvestrant
| Fulvestrant | |
|---|---|
| Term | Fulvestrant |
| Short definition | Fulphila (FUL-fih-luh) A drug that is a form of filgrastim and is used to prevent infections in adults and children with neutropenia (a lower than normal white blood cell count), caused by some types of chemotherapy. Fulphila helps the bone marrow make more white blood cells and can stay in the body longer than filgrastim, so it doesn't need to be given as often. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Fulvestrant - (pronounced) (ful-VES-trut) A drug used to treat certain types of breast cancer. It is used alone or with ribociclib succinate in postmenopausal women who have not received hormone therapy or whose disease has gotten worse after hormone therapy. It is also used with palbociclib or abemaciclib in women whose disease has got worse after treatment with hormone therapy. It is also being studied in the treatment of other types of cancer. Fulvestrant attaches to proteins called estrogen receptors that are found in some breast cancer cells. These proteins can cause cancer cells to grow. Fulvestrant blocks these proteins and can stop cancer cells from growing. It's kind of an anti-estrogen. Also called Faslodex and ICI 182780
External links
- Medical encyclopedia article on Fulvestrant
- Wikipedia's article - Fulvestrant
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski